Natera
NTRA
$44.25
Share price
-2.36%
Change (1 day)
-9.68%
Change (1 year)
Categories
Revenue for Natera (NTRA)
Revenue in 2023 (TTM): $0.93 B
According to Natera's latest financial reports the company's current revenue (TTM) is $0.93 B. In 2022 the company made a revenue of $0.82 B an increase over the years 2021 revenue that were of $0.62 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Natera from 2014 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.93 B | 13.51% |
| 2022 | $0.82 B | 31.13% |
| 2021 | $0.62 B | 59.97% |
| 2020 | $0.39 B | 29.33% |
| 2019 | $0.30 B | 17.34% |
| 2018 | $0.25 B | 22.15% |
| 2017 | $0.21 B | -2.83% |
| 2016 | $0.21 B | 14.04% |
| 2015 | $0.19 B | 19.5% |
| 2014 | $0.15 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | $9.50 B | 920.89% | 🇺🇸 USA |
 Prothena PRTA | $57.62 M | -93.81% | 🇮🇪 Ireland |
 Paratek Pharmaceuticals
PRTK | $0.16 B | -81.98% | 🇺🇸 USA |